| Followers | 18 |
| Posts | 1681 |
| Boards Moderated | 0 |
| Alias Born | 09/10/2014 |
Saturday, June 11, 2016 2:22:46 PM
NO, they don't really think Linda is trying to bankrupt NWBO - they want to get more longs worried and confused enough to sell their shares.
She said in the last PR she would be putting together a Scientific Advisory Board. Is that something you do before you bankrupt it? The trial information is being reviewed by a regulator - is that something you do before you bankrupt a company? the technology for manufacturing is being optimized to prepare for new trials - need I ask the question again?
Equating a lack of loose lips with plans to go bankrupt makes no realistic sense. Selling right before the possibility of imminent news is the last thing I would do, or recommend for anyone else.
Remember, if you are selling, someone is buying, and they will be getting your shares for a steal! There is no concern for the buyers being expressed, only that they want to part you from your shares. You might find out in the end that the silence was good, the Cognate deal was favorable,the trial is successful, and many other good things, but if you sell....too bad.
She said in the last PR she would be putting together a Scientific Advisory Board. Is that something you do before you bankrupt it? The trial information is being reviewed by a regulator - is that something you do before you bankrupt a company? the technology for manufacturing is being optimized to prepare for new trials - need I ask the question again?
Equating a lack of loose lips with plans to go bankrupt makes no realistic sense. Selling right before the possibility of imminent news is the last thing I would do, or recommend for anyone else.
Remember, if you are selling, someone is buying, and they will be getting your shares for a steal! There is no concern for the buyers being expressed, only that they want to part you from your shares. You might find out in the end that the silence was good, the Cognate deal was favorable,the trial is successful, and many other good things, but if you sell....too bad.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
